Hims & Hers Health (HIMS) Liabilities and Shareholders Equity (2019 - 2026)

Hims & Hers Health (HIMS) has 8 years of Liabilities and Shareholders Equity data on file, last reported at $2.3 billion in Q1 2026.

• For the quarter ending Q1 2026, Liabilities and Shareholders Equity rose 154.24% year-over-year to $2.3 billion; the trailing twelve-month figure through Mar 2026 stood at $8.5 billion (up 218.14% YoY), and the FY2025 full-year result was $2.2 billion, up 204.54% from the prior year.
• Liabilities and Shareholders Equity advanced to $2.3 billion in Q1 2026, from $2.2 billion in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $2.3 billion in Q1 2026 to a low of $366.3 million in Q4 2022.
• A 5-year average of $870.3 million and a median of $448.1 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• Across the five-year window, Liabilities and Shareholders Equity decreased 12.9% in 2022 and soared 290.76% in 2025, its largest moves.
• Tracing HIMS's Liabilities and Shareholders Equity over 5 years: stood at $366.3 million in 2022, then advanced by 20.43% to $441.2 million in 2023, then surged by 60.37% to $707.5 million in 2024, then soared by 204.54% to $2.2 billion in 2025, then rose by 5.21% to $2.3 billion in 2026.
• Business Quant data shows HIMS's Liabilities and Shareholders Equity at $2.3 billion in Q1 2026, $2.2 billion in Q4 2025, and $2.2 billion in Q3 2025.